Group 1 - Company announced that its subsidiary, Shandong Danhong, plans to sign a technology transfer contract with Shandong University of Traditional Chinese Medicine Affiliated Hospital for the transfer of the proprietary technology of the Chinese medicine "Erzhi Tiaojing Optimization Formula" for a total price of 15 million RMB [2] - The contract will facilitate the research and industrial-scale production of a new Chinese medicine, adhering to the relevant regulations and requirements [2] - The board of directors approved the proposal regarding the technology transfer, which falls within the approval authority of the board and does not require shareholder meeting review [2]